Special Issue "Anticancer Drugs 2021"

被引：2

作者：

Meegan, Mary J. ^{[1
]}

O'Boyle, Niamh M. ^{[1
]}

机构：

[1] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, 152-160 Pearse St, Dublin DO2R590 2, Ireland

来源：

PHARMACEUTICALS | 2022年 / 15卷 / 04期

关键词：

DERIVATIVES;

D O I：

10.3390/ph15040479

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页数：5

共 24 条

[1] Synthesis of New 1, 3, 4-Oxadiazole-Incorporated 1, 2, 3-Triazole Moieties as Potential Anticancer Agents Targeting Thymidylate Synthase and Their Docking Studies [J].

Alam, Mohammad Mahboob ;

Almalki, Abdulraheem S. A. ;

Neamatallah, Thikryat ;

Ali, Nada M. ;

Malebari, Azizah M. ;

Nazreen, Syed .

PHARMACEUTICALS, 2020, 13 (11) :1-15

[2] Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer [J].

Ana, Gloria ;

Kelly, Patrick M. ;

Malebari, Azizah M. ;

Noorani, Sara ;

Nathwani, Seema M. ;

Twamley, Brendan ;

Fayne, Darren ;

O'Boyle, Niamh M. ;

Zisterer, Daniela M. ;

Pimentel, Elisangela Flavia ;

Endringer, Denise Coutinho ;

Meegan, Mary J. .

PHARMACEUTICALS, 2021, 14 (02) :1-59

[3] Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures [J].

Balandis, Benas ;

Mickevicius, Vytautas ;

Petrikaite, Vilma .

PHARMACEUTICALS, 2021, 14 (11)

[4] Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2 [J].

Balbuena-Rebolledo, Irving ;

Padilla-Martinez, Itzia Irene ;

Rosales-Hernandez, Martha Cecilia ;

Bello, Martiniano .

PHARMACEUTICALS, 2021, 14 (08)

[5] Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line [J].

Elrayess, Ranza ;

Abdel Aziz, Yasmine M. ;

Elgawish, Mohamed Saleh ;

Elewa, Marwa ;

Yassen, Asmaa S. A. ;

Elhady, Sameh S. ;

Elshihawy, Hosam A. ;

Said, Mohamed M. .

PHARMACEUTICALS, 2021, 14 (01) :1-21

[6] Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma [J].

Espadinha, Margarida ;

Barcherini, Valentina ;

Goncalves, Lidia M. ;

Molins, Elies ;

Antunes, Alexandra M. M. ;

Santos, Maria M. M. .

PHARMACEUTICALS, 2021, 14 (03)

[7] Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones [J].

Gargantilla, Marta ;

Lopez-Fernandez, Jose ;

Camarasa, Maria-Jose ;

Persoons, Leentje ;

Daelemans, Dirk ;

Priego, Eva-Maria ;

Perez-Perez, Maria-Jesus .

PHARMACEUTICALS, 2021, 14 (11)

[8] TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs [J].

Han, Sun-Young .

PHARMACEUTICALS, 2021, 14 (07)

[9] Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors [J].

Ibrahim, Tarek S. ;

Malebari, Azizah M. ;

Mohamed, Mamdouh F. A. .

PHARMACEUTICALS, 2021, 14 (11)

[10] Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades [J].

Imran, Mohd. ;

Asdaq, Syed Mohammed Basheeruddin ;

Khan, Shah Alam ;

Unnikrishnan Meenakshi, Dhanalekshmi ;

Alamri, Abdulhakeem S. ;

Alsanie, Walaa F. ;

Alhomrani, Majid ;

Mohzari, Yahya ;

Alrashed, Ahmed ;

AlMotairi, Mohammed ;

Alkhaldi, Eman H. ;

Alorabi, Abeer K. ;

Alshrari, Ahmed Subeh ;

Tauseef, Mohammad ;

Abida ;

Alaqel, Saleh I. ;

Alam, Ozair ;

Bakht, Md. Afroz .

PHARMACEUTICALS, 2021, 14 (08)

← 1 2 3 →